NCT07548086

Brief Summary

The goal of this clinical trial is to learn whether a non-invasive light-based test called Spatially Resolved Near-Infrared Spectroscopy (SR-NIRS) can measure blood flow and oxygen levels in the testicles of children. The study includes boys aged 1 month to 18 years, including those without testicular problems (part 1) and those with sudden scrotal pain (part 2). Testicular torsion is a condition where the blood supply to the testicle becomes twisted and reduced. This can lead to permanent damage if not treated quickly. Current methods, such as ultrasound or surgery, may not always be immediately available and can sometimes lead to delays or unnecessary procedures. This study explores whether SR-NIRS can provide useful information about blood flow and oxygen levels in painful testicles of the children. The main questions the study aims to answer are:

  • Part 1 (Feasibility study, n=24) Can SR-NIRS reliably collect usable measurements in healthy children?
  • Part 2 (exploratory study, n=50): Do SR-NIRS measurements differ between children with and without torsion? Participants will:
  • Have a small probe placed on the skin over the testicle(s) and thigh
  • Undergo a brief measurement during a single visit This study will not affect diagnosis or treatment. The results will help guide future research.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
37mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2029

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2029

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

3 years

First QC Date

March 31, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

Feasibility studyExploratory StudyNear-infrared spectroscopyPediatric Urology

Outcome Measures

Primary Outcomes (2)

  • Part 1- Feasibility of the investigational SR-NIRS device for successful acquisition of interpretable tissue oxygenation and perfusion signals from pediatric testicular tissue in children with clinically unaffected testes.

    Percentage of participants with at least 30 seconds of interpretable, artifact-free SR-NIRS recordings obtained at both measurement sites (testis and ipsilateral thigh reference site)

    Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).

  • Part 2- Difference in Regional Tissue Perfusion Index (RTPI) between torsion and non-torsion presentations in children with acute scrotum

    Participant-level standardized RTPI, defined as: \[RTPI in affected testicle -RTPI in unaffected testicle/ RTPI in unaffected testicle\] x100 will be compared between torsion and non-torsion groups.

    Day1; The outcome is measured immediately after the completion of the NIRS test (intervention)

Secondary Outcomes (4)

  • Part 2- Difference in TOI between torsion and non-torsion presentation in children with acute scrotum.

    Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).

  • Part 1- Reference ranges for SR-NIRS-derived parameters (HbO₂, HHb, THb, TOI, RTPI) in children with unaffected testis.

    Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).

  • Part 2-Differences in SR-NIRS tissue oxygenation parameters (Oxygenated hemoglobin (O₂Hb), Deoxygenated hemoglobin (HHb), Total hemoglobin (THb)) between children with and without torsion.

    Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).

  • Part 1 and Part 2-Safety and tolerability of SR-NIRS measurements

    Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).

Study Arms (2)

Healthy Controls

EXPERIMENTAL

Part 1 study, SR-NIRS signal acquisition from testis and ipsilateral upper thigh, each for one minute

Device: SR-NIRS

Testicular Torsion Cases

EXPERIMENTAL

Part 2 study, SR-NIRS signal recording of at least one minute from affected testis, contralateral testis, and upper thigh.

Device: SR-NIRS

Interventions

SR-NIRSDEVICE

Feasibility in Healthy Control

Healthy Controls

Eligibility Criteria

Age1 Month - 18 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Part 1:
  • Boys aged 1 month to 18 years.
  • Presenting to the urology clinic with non-testicular complaints.
  • Part 2:
  • Boys aged 1 month to 18 years.
  • Presenting to the Emergency Room or urology clinic with acute scrotum, defined as a TWIST (Testicular Workup for Ischemia and Suspected Torsion) score ≥ 1.

You may not qualify if:

  • Part 1:
  • Any scrotal or testicular pathology, including hydrocele, inguinal hernia, undescended testicle, varicocele, or scrotal pain.
  • History of testicular or scrotal surgery, except unilateral orchiopexy. Unable or unwilling to provide consent/assent
  • Part 2:
  • Boys with a history of testicular surgery, scrotal surgery, inguinal hernia, hydrocele, varicocele, or undescended testicle.
  • Unable or unwilling to provide consent/assent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Children's Hospital

Vancouver, British Columbia, Canada

Location

MeSH Terms

Conditions

Spermatic Cord Torsion

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Kourosh Afshar, MD, FRCSC

    University of British Columbia, Department of Urologic Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maryam Noparast, MD, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The person interpreting SR-NIRS signals is blind to the final diagnosis of the participants in part 2 (testicular torsion vs other).
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Model Details: This is a sequential design. Phase 1 is for determination of feasibility and phase 2 for assessment of diagnostic ability/accuracy.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor, Urologic Sciences, Faculty of Medicine, University of British Columbia

Study Record Dates

First Submitted

March 31, 2026

First Posted

April 23, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2029

Study Completion (Estimated)

September 1, 2029

Last Updated

April 23, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations